Measurement Of Serum Levels Of Two Antiepileptic Drugs During Conversion In Patients With Epilepsy
Clinical trial NCT00043914 · COMPLETED
Trial details
- NCT number
- NCT00043914
- Sponsor
- GlaxoSmithKline
- Status
- COMPLETED
- Phase
- Phase 4
- Study type
- INTERVENTIONAL
- Start date
- 2002-01-14
- Primary completion
- 2003-01-29
- Enrollment
- 72
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.